価格表

在庫・価格 : 2025年04月26日 08時45分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Kallikrein 3, Human, ELISA Kit, Quantikine (96well) <KLK3, ELISA Kit><PSA, ELISA Kit>
データシート※最新のデータシートでない場合があります
DKK300 RSDアールアンドディー システムズ
R&D Systems, Inc.
1 kit ¥116,000
(未発注)
追加

在庫・価格 : 2025年04月26日 08時45分 現在

Kallikrein 3, Human, ELISA Kit, Quantikine (96well) <KLK3, ELISA Kit><PSA, ELISA Kit>

  • 商品コード:DKK300
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥116,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Deep G et al. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway. Oncogene 2008 Jun;27(28):3986-98
Deep G et al
2008/01/01
Species: Human, Application: Cell Supernates PubMed
2 Russo AL et al. Urine analysis and protein networking identify met as a marker of metastatic prostate cancer. Clin. Cancer Res. 2009 Jul;15(13):4292-8
Russo AL et al
2009/01/01
Sample Type: Cell Supernates PubMed
3 Kim SH et al. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells. Mol. Cancer Ther. 2009 Jul;8(7):1946-54
Kim SH et al
2009/01/01
Sample Type: Cell Supernates PubMed
4 Stan SD et al. Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells. Clin. Cancer Res. 2009 Aug;15(15):4895-903
Stan SD et al
2009/01/01
Sample Type: Cell Supernates,Cells Supernates PubMed
5 Darmanis S et al. Sensitive plasma protein analysis by microparticle-based proximity ligation assays. Mol. Cell Proteomics 2010 Feb;9(2):327-35
Darmanis S et al
2010/01/01
Sample Type: Plasma (Not Specified) PubMed
6 Squillace RM et al. Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models. Int. J. Oncol. 2012 Aug;41(2):425-32
Squillace RM et al
2012/01/01
Sample Type: Cell Culture Supernates PubMed
7 Windus LC et al. In vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer. Exp. Cell Res. 2012 Nov;318(19):2507-19
Windus LC et al
2012/01/01
Sample Type: Cell Culture Supernates PubMed
8 Colquhoun AJ et al. Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. Prostate Cancer Prostatic Dis. 2012 Dec;15(4):346-52
Colquhoun AJ et al
2012/01/01
Sample Type: Serum PubMed
9 Yang F et al. Antitumor activity of a pyrrole-imidazole polyamide. Proc. Natl. Acad. Sci. U.S.A. 2013 Jan;110(5):1863-8
Yang F et al
2013/01/01
Sample Type: Serum PubMed
10 Eswaraka J et al. Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer. BMC Cancer 2014;14:742
Eswaraka J et al
2014/01/01
Sample Type: Plasma PubMed
11 Sanna V et al. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci Rep 2017 Feb;7:41573
Sanna V et al
2017/01/01
Sample Type: Serum PubMed
12 Suominen MI et al. Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models. Clin. Cancer Res. 2017 Aug;23(15):4335-4346
Suominen MI et al
2017/01/01
Species: Mouse PubMed
13 Jarrard D et al. Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy. Am J Clin Exp
Jarrard D et al
2016/01/01
Species: Human PubMed
14 DSouza AL et al. Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence. PLoS ONE 2018;13(3):e0194268
DSouza AL et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Deep G et al. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway. Oncogene 2008 Jun;27(28):3986-98
    Deep G et al
    2008/01/01
  • 備考:
    Species: Human, Application: Cell Supernates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Russo AL et al. Urine analysis and protein networking identify met as a marker of metastatic prostate cancer. Clin. Cancer Res. 2009 Jul;15(13):4292-8
    Russo AL et al
    2009/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kim SH et al. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells. Mol. Cancer Ther. 2009 Jul;8(7):1946-54
    Kim SH et al
    2009/01/01
  • 備考:
    Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Stan SD et al. Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells. Clin. Cancer Res. 2009 Aug;15(15):4895-903
    Stan SD et al
    2009/01/01
  • 備考:
    Sample Type: Cell Supernates,Cells Supernates
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Darmanis S et al. Sensitive plasma protein analysis by microparticle-based proximity ligation assays. Mol. Cell Proteomics 2010 Feb;9(2):327-35
    Darmanis S et al
    2010/01/01
  • 備考:
    Sample Type: Plasma (Not Specified)
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Squillace RM et al. Synergistic activity of the mTOR inhibitor ridaforolimus and the antiandrogen bicalutamide in prostate cancer models. Int. J. Oncol. 2012 Aug;41(2):425-32
    Squillace RM et al
    2012/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Windus LC et al. In vivo biomarker expression patterns are preserved in 3D cultures of Prostate Cancer. Exp. Cell Res. 2012 Nov;318(19):2507-19
    Windus LC et al
    2012/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Colquhoun AJ et al. Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer. Prostate Cancer Prostatic Dis. 2012 Dec;15(4):346-52
    Colquhoun AJ et al
    2012/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Yang F et al. Antitumor activity of a pyrrole-imidazole polyamide. Proc. Natl. Acad. Sci. U.S.A. 2013 Jan;110(5):1863-8
    Yang F et al
    2013/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Eswaraka J et al. Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer. BMC Cancer 2014;14:742
    Eswaraka J et al
    2014/01/01
  • 備考:
    Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Sanna V et al. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci Rep 2017 Feb;7:41573
    Sanna V et al
    2017/01/01
  • 備考:
    Sample Type: Serum
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Suominen MI et al. Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models. Clin. Cancer Res. 2017 Aug;23(15):4335-4346
    Suominen MI et al
    2017/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Jarrard D et al. Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy. Am J Clin Exp
    Jarrard D et al
    2016/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    DSouza AL et al. Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence. PLoS ONE 2018;13(3):e0194268
    DSouza AL et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed